Related Experiment Videos
Retinoids as chemopreventive agents.
1Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. ralhanr@rediffmail.com
Summary
Retinoids show promise for cancer chemoprevention by targeting specific receptors. Research focuses on developing safer, more effective synthetic retinoids with reduced toxicity for cancer therapy.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Retinoids exert pleiotropic effects on cellular processes like differentiation and apoptosis.
- These effects are mediated by retinoid and rexinoid receptors, forming a complex signaling network.
- Understanding retinoid signaling is crucial for cancer chemoprevention and therapy.
Purpose of the Study:
- To review recent advances in the molecular mechanisms of retinoid action.
- To discuss retinoid molecular targeting strategies for developing reduced-toxicity agents.
- To evaluate the clinical efficacy of retinoid-based chemoprevention trials.
Main Methods:
- Literature review of recent advances in retinoid research.
- Analysis of molecular mechanisms underlying retinoid-induced anti-proliferation and apoptosis.
- Discussion of retinoid molecular targeting and synthetic retinoid development.
Main Results:
- Retinoid signaling complexity arises from receptor interactions, co-activator/co-repressor involvement, and cross-talk with other pathways.
- Development of receptor-selective synthetic retinoids is a key focus.
- Novel strategies include identifying new retinoid-regulated genes and exploring receptor-independent apoptosis induction.
Conclusions:
- Elucidation of retinoid pathways enables the design of synthetic retinoids for cancer chemoprevention and therapy.
- Developing retinoids with reduced toxicity while maintaining efficacy is a primary goal.
- Clinical trials are essential for validating the efficacy of retinoid-based chemoprevention.